Combined Immunotherapy with Chemotherapy versus Bevacizumab with Chemotherapy in First-Line Treatment of Driver-Gene-Negative Non-Squamous Non-Small Cell Lung Cancer: An Updated Systematic Review and Network Meta-Analysis

Background: A network meta-analysis was conducted to summarize randomized control trials and updated results to evaluate the efficacy and safety profiles of existing first-line therapies for advanced non-squamous non-small cell lung cancer (NSCLC) patients without known driver gene mutations. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Yue, Wu, Xinyu, Bai, Hua, Duan, Jianchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956069/
https://www.ncbi.nlm.nih.gov/pubmed/35329978
http://dx.doi.org/10.3390/jcm11061655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956069/
https://www.ncbi.nlm.nih.gov/pubmed/35329978
http://dx.doi.org/10.3390/jcm11061655

Ejemplares similares